Dr. Scott Hartley
Dr. Scott Hartley is the CEO of Proengin Inc. which develops and manufactures chemical and biological detection systems. In this role, Dr. Hartley is responsible leading and directing Proengin operations in North American. Proengin is a leader in flame spectroscopy technology which is able to quickly and precisely identify key materials found in chemical warfare agents, precursor materials, binary agents, fourth generation agents as well as many toxic industrial chemicals. This technology is also able to identify key biological materials found in toxins, bacteria and spores. Proengin technology has been adopted for use in over 72 countries and is used for military, first responder, HAZMAT, chemical and security applications.
Prior to joining Proengin, Dr. Hartley was served in various Business Development roles for BAE Systems/Armor Holdings where he worked on personal protective equipment and combat vehicles. He also previously worked at Gentex Corporation where he held various engineering, program management and general management roles. Dr. Hartley holds BS degrees in Mechanical Engineering and Mathematics from Cedarville University, dual MBA’s in Finance and Operations Management from the University of Scranton, and a Doctorate of Management degree in Technology Systems Management from the University of Maryland. He holds 11 patents and serves on the Board of Directors for the Warrior Protection and Readiness Coalition.